Correlation Between Surrozen Warrant and Humacyte

Can any of the company-specific risk be diversified away by investing in both Surrozen Warrant and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen Warrant and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Surrozen Warrant and Humacyte, you can compare the effects of market volatilities on Surrozen Warrant and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen Warrant with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen Warrant and Humacyte.

Diversification Opportunities for Surrozen Warrant and Humacyte

-0.2

Correlation Coefficient

Surrozen Warrant  Humacyte

Good diversification

The 3 months correlation between Surrozen and Humacyte is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen Warrant and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Surrozen Warrant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen Warrant are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Surrozen Warrant i.e., Surrozen Warrant and Humacyte go up and down completely randomly.

Pair Corralation between Surrozen Warrant and Humacyte

Assuming the 90 days horizon Surrozen Warrant is expected to generate 4.24 times more return on investment than Humacyte. However, Surrozen Warrant is 4.24 times more volatile than Humacyte. It trades about 0.11 of its potential returns per unit of risk. Humacyte is currently generating about -0.18 per unit of risk. If you would invest  1.97  in Surrozen Warrant on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Surrozen Warrant or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	59.09%
Values	Daily Returns

Surrozen Warrant  vs.  Humacyte

Surrozen Warrant

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen Warrant are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Surrozen Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Humacyte

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Humacyte may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Surrozen Warrant and Humacyte

The main advantage of trading using opposite Surrozen Warrant and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen Warrant position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.

The idea behind Surrozen Warrant and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.